MF
Contributor Foti, Michelangelo
Breakdown by access level
Textual representation
| Access level | |
|---|---|
| Public access | 2 |
Distribution by access level (last 10 years)
Textual representation
| Access level | Public access | Restricted access | Closed access | No fulltext |
|---|---|---|---|---|
| 2017 | ||||
| 2018 | ||||
| 2019 | ||||
| 2020 | ||||
| 2021 | ||||
| 2022 | ||||
| 2023 | ||||
| 2024 | ||||
| 2025 | ||||
| 2026 | 2 |
Distribution according to UNIGE OA policy
Textual representation
| Open access policy | Open Access | Still embargoed | Not Open Access |
|---|---|---|---|
| 2 |
List of publications by Foti, Michelangelo
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors | Cancer letters | 2026 | 32 | 129 | |||
| S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids | EMBO molecular medicine | 2026 | 12 | 36 |
